BGF backs DefiniGEN in GBP3.25m funding round
DefiniGEN – a provider of human cell products and services – has closed a GBP3.25 million funding round to accelerate its next phase of growth. This includes GBP2 million from BGF, the UK’s most active investor, alongside its existing consortium of investors led by 24Haymarket.DefiniGEN is a spin-out from the